Saphena Medical, founded with a mission to revolutionize cardiovascular care, focuses on developing advanced medical devices. Its core product, Venapax, is an all-in-one system designed for endoscopic vessel harvesting, which simplifies the dissection and simultaneous branch ligation process. This innovative device aims to enhance graft quality through a minimal-touch approach, addressing the challenges traditionally associated with the endoscopic vessel harvesting learning curve. Saphena Medical targets healthcare providers and institutions specializing in cardiovascular surgery.

Notable figures affiliated with Saphena Medical include experienced professionals in the medical device industry and cardiovascular surgery. The company has attracted investment from prominent venture capital firms specializing in healthcare innovation. Key achievements include the successful development and market introduction of Venapax, which has been recognized for its potential to improve surgical outcomes and patient care. Saphena Medical's impact is marked by its contribution to advancing minimally invasive cardiovascular procedures, ultimately aiming to enhance patient recovery and surgical efficiency.